TrialAnnals of oncology : official journal of the European Society for Medical Oncology2017

Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial.

H R Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.